Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Global Crossing Airlines Reports Record Fourth Quarter Revenue & Meaningfully Improved Full Year 2024 Financial Results
-
FRP Holdings, Inc. (NASDAQ: FRPH) Announces Results for the Fourth Quarter and Year Ended December 31, 2024
-
Zscaler Reports Second Quarter Fiscal 2025 Financial Results
-
Ultra Clean Announces Clarence Granger as Interim CEO
-
LENDINGTREE REPORTS FOURTH QUARTER 2024 RESULTS
-
Marvell Technology, Inc. Reports Fourth Quarter and Fiscal Year 2025 Financial Results
-
Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
-
MongoDB, Inc. Announces Fourth Quarter and Full Year Fiscal 2025 Financial Results
-
Identiv Reports Fourth Quarter and Fiscal Year 2024 Financial Results
-
Cyngn Reports 2024 Fourth Quarter and Year-End Financial Results
-
Veeva Announces Fourth Quarter and Fiscal Year 2025 Results
-
Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance
-
Stonegate Capital Partners Updates 4Q24 Report on OppFi, Inc. (NYSE: OPFI)
-
Yext Announces Fourth Quarter Fiscal 2025 Results
-
Vaxart Announces Publication Demonstrating the Immunogenicity and Safety of its First-Generation Oral Pill Norovirus Vaccine Candidate in Elderly Adults
-
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
-
Hub Group Declares Quarterly Dividend
-
Grindr Inc. Delivers 33% Full Year 2024 Revenue Growth
-
Virtus Convertible & Income Fund II Announces Quarterly Distribution: 5.500% Series A Cumulative Preferred Shares
-
Amplify Energy Announces Fourth Quarter and Full-Year 2024 Results, Year-End 2024 Proved Reserves, Juniper Capital Acquisition Update and Standalone Full-Year 2025 Guidance
-
Limbach Holdings to Participate in Upcoming UBS and Roth Investor Conferences
-
Lesaka completes the acquisition of Recharger
-
Micron Appoints Mark Liu and Christie Simons to Board of Directors
-
Enovis to Participate in Upcoming Investor Conferences
-
ACM Research to Participate at the 37th Annual ROTH Conference
-
Silvaco Reports Fourth Quarter and Full Year 2024 Financial Results
-
Climb Global Solutions Reports Record Fourth Quarter and Full Year 2024 Results
-
Tactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
-
Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025
-
Lesaka completes the acquisition of Recharger
-
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
-
Editas Medicine Announces Fourth Quarter and Full Year 2024 Results and Business Updates
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
MU DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Micron Technology, Inc. Investors to Secure Counsel Before Important March 10 Deadline in Securities Class Action - MU
-
Maryland Taxpayers Beware: Protect Yourself from Scam Tax Preparers
-
Evertz Technologies Reports Record Quarterly Revenue of $137 Million in The Third Quarter Ended January 31, 2025
-
Alpha Genesis Proposes Innovative Management Model to Transform National Primate Research Centers
-
KBRA Assigns Preliminary Ratings to GS Mortgage-Backed Securities Trust 2025-CES1 (GSMBS 2025-CES1)
-
Aircraft Values Hold Steady During Seasonal Inventory Decreases
-
Journey Medical Corporation Announces Publication in the Journal of the American Medical Association - Dermatology of the Phase 3 Clinical Trial Results of Emrosi™ (DFD-29) to Treat Rosacea
-
Aware Reports Fourth Quarter and Full Year 2024 Financial Results
-
Sleep Number Announces Fourth Quarter and Full Year 2024 Results
-
Google Cloud Brings WeatherNext AI-Powered Weather Predictions to Enterprises
-
CPS Technologies Announces Phase I SBIR Contract from the U.S. Army
-
Franklin Resources, Inc. Announces Preliminary Month-End Assets Under Management
-
Virpax’s NES100 to be Presented at The Society of Toxicology by NCATS
-
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
-
WORK Medical Technology Group LTD Announces Implementation of Dual-Class Share Structure Effective March 6, 2025
-
Fate Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates
-
Plus Therapeutics Announces New Employment Inducement Grants
